Neuro-Oncology Reviews

Volume 24 Number 15
15 August 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 15, 15 August

*

Cabezas-Camarero S, Pérez-Alfayate R, Sotelo MJ.
Glioblastoma: an organ-confined disease?
Transl Cancer Res. 2022 Aug;11(8):2473-2476→. doi: 10.21037/tcr-22-1943→. PMID: 36093531→. Editorial. ˍ
Refers to: Chai M, et al., Extracranial metastasis of glioblastoma with genomic analysis: a case report and review of the literature.
Transl Cancer Res. 2022 Aug;11(8):2917-2925→. doi: 10.21037/tcr-22-955→. PMID: 36093544→. Case report, Review. ˍ

Chai M, Shi Q.
Extracranial metastasis of glioblastoma with genomic analysis: a case report and review of the literature.
Transl Cancer Res. 2022 Aug;11(8):2917-2925→. doi: 10.21037/tcr-22-955→. PMID: 36093544→. Case report, Review. ˍ

Wu JY, Ren AL, Lim M.
Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review.
Chin Clin Oncol. 2022 Aug;11(4):26→. doi: 10.21037/cco-22-58→. PMID: 36098097→. Review. ˍ

Zhao MJ, Lu T, Ma C, Wang ZF, Li ZQ.
A narrative review on the management of glioblastoma in China.
Chin Clin Oncol. 2022 Aug;11(4):29→. doi: 10.21037/cco-22-18→. PMID: 36098100→. Review. ˍ

Jo J, Schiff D.
Current Considerations in the Treatment of Grade 3 Gliomas.
Curr Treat Options Oncol. 2022 Aug 1→. doi: 10.1007/s11864-022-01000-z→. PMID: 35913658→. Review˰ ˍ

Rudà R, Capper D, Waldman AD, Pallud J, Minniti G, Kaley TJ, Bouffet E, Tabatabai G, Aronica E, Jakola AS, Pfister SM, Schiff D, Lassman AB, Solomon DA, Soffietti R, Weller M, Preusser M, Idbaih A, Wen PY, van den Bent MJ.
Eano-Euracan-Sno Guidelines on Circumscribed Astrocytic GLIOMAS, Glioneuronal and Neuronal tumors.
Neuro Oncol. 2022 Aug 1:noac188→. doi: 10.1093/neuonc/noac188→. PMID: 35908833→. Guidelines˰ ˍ

Sankhyan M, Anderson EM, Urquiaga JF, Hockman JT, Aggarwal R, El Tecle NE, Mercier PJ.
Urothelial Carcinoma of the Bladder With Primary Metastasis to the Brain: A Case Report and Literature Review.
Cureus. 2022 Aug 1;14(8):e27587→. doi: 10.7759/cureus.27587→. PMID: 36059295→. Case report, Review. ˍ

Taylor C, Ekert JO, Sefcikova V, Fersht N, Samandouras G.
Discriminators of pseudoprogression and true progression in high-grade gliomas: A systematic review and meta-analysis.
Sci Rep. 2022 Aug 2;12(1):13258→. doi: 10.1038/s41598-022-16726-x→. PMID: 35918373→. Review, Meta-analysis. ˍ

Onishi S, Yamasaki F, Amatya VJ, Takayasu T, Yonezawa U, Taguchi A, Ohba S, Takeshima Y, Horie N, Sugiyama K.
Characteristics and therapeutic strategies of radiation-induced glioma: case series and comprehensive literature review.
J Neurooncol. 2022 Aug 3→. doi: 10.1007/s11060-022-04090-9→. PMID: 35922583→. Case reports, Review˰ ˍ

Panovska D, De Smet F.
Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?
Int J Mol Sci. 2022 Aug 3;23(15):8637→. doi: 10.3390/ijms23158637→. PMID: 35955765→. Review. ˍ

Qin D, Yang G, Jing H, Tan Y, Zhao B, Zhang H.
Tumor Progression and Treatment-Related Changes: Radiological Diagnosis Challenges for the Evaluation of Post Treated Glioma.
Cancers (Basel). 2022 Aug 3;14(15):3771→. doi: 10.3390/cancers14153771→. PMID: 35954435→. Review. ˍ

Sun R, Kim AH.
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications.
Cancer Metastasis Rev. 2022 Aug 3→. doi: 10.1007/s10555-022-10051-5→. PMID: 35920986→. Review. ˍ

Haizel-Cobbina J, Thakkar R, Richard K, Du L, Levine A, Bennett J, Hawkins C, Tabori U, Dewan MC.
Clinical and molecular features of disseminated pediatric low-grade glioma and glioneuronal tumors: a systematic review and survival analysis.
Neurooncol Adv. 2022 Aug 5;4(1):vdac122→. doi: 10.1093/noajnl/vdac122→. PMID: 36382112→. Review. ˍ

Luo M, Yang J, Sun J, Wang F, Chai X.
Primary gliosarcoma with widespread extracranial metastases-spatiotemporal morphological variation.
Chin Neurosurg J. 2022 Aug 5;8(1):20→. doi: 10.1186/s41016-022-00285-1→. PMID: 35932030→. Case reports, Review. ˍ

*

Gunjur A, Balasubramanian A, Hafeez U, Menon S, Cher L, Parakh S, Gan HK.
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review.
J Neurooncol. 2022 Aug 6→. doi: 10.1007/s11060-022-04092-7→. PMID: 35933567→. Review˰ ˍ

Asija S, Chatterjee A, Yadav S, Chekuri G, Karulkar A, Jaiswal AK, Goda JS, Purwar R.
Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Int Rev Immunol. 2022 Aug 8:1-24→. doi: 10.1080/08830185.2022.2101647→. PMID: 35938932→. Review˰ ˍ

Leone A, Colamaria A, Fochi NP, Sacco M, Landriscina M, Parbonetti G, de Notaris M, Coppola G, De Santis E, Giordano G, Carbone F.
Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era.
Biomedicines. 2022 Aug 9;10(8):1927→. doi: 10.3390/biomedicines10081927→. PMID: 36009473→. Review. ˍ

Yuan E, Liu K, Lee J, Tsung K, Chow F, Attenello FJ.
Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes.
Neurooncol Adv. 2022 Aug 10;4(1):vdac119→. doi: 10.1093/noajnl/vdac119→. PMID: 36105389→. Review. ˍ

Pan Y, Monje M.
Neuron-Glial Interactions in Health and Brain Cancer.
Adv Biol (Weinh). 2022 Aug 11:e2200122→. doi: 10.1002/adbi.202200122→. PMID: 35957525→. Review˰ ˍ

*

Zhang D, Zhu W, Guo J, Chen W, Gu X.
Application of artificial intelligence in glioma researches: A bibliometric analysis.
Front Oncol. 2022 Aug 11;12:978427→. doi: 10.3389/fonc.2022.978427→. PMID: 36033537→. Bibliometric analysis. ˍ

Giotta Lucifero A, Luzzi S.
Emerging immune-based technologies for high-grade gliomas.
Expert Rev Anticancer Ther. 2022 Aug 12:1-24→. doi: 10.1080/14737140.2022.2110072→. PMID: 35924820→. Review˰ ˍ

Hoang-Xuan K, Deckert M, Ferreri AJM, Furtner J, Gallego Perez-Larraya J, Henriksson R, Hottinger AF, Kasenda B, Lefranc F, Lossos A, McBain C, Preusser M, Roth P, Rudà R, Schlegel U, Soffietti R, Soussain C, Taphoorn MJB, Touitou V, Weller M, Bromberg JEC.
European Association of Neuro-Oncology (EANO) Guidelines for Treatment of Primary Central Nervous System lymphoma (PCNSL).
Neuro Oncol. 2022 Aug 12:noac196→. doi: 10.1093/neuonc/noac196→. PMID: 35953526→. Guidelines˰ ˍ

Omuro A.
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
Arq Neuropsiquiatr. 2011 Aug 12;80(5 Suppl 1):266-269→. doi: 10.1590/0004-282X-ANP-2022-S129→. PMID: 35976319→. Review. ˍ

Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD.
Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis.
Front Oncol. 2022 Aug 12;12:893855→. doi: 10.3389/fonc.2022.893855→. PMID: 36033525→. Review, Meta-analysis. ˍ

Thomas S, Bikeyeva V, Abdullah A, Radivojevic A, Abu Jad AA, Ravanavena A, Ravindra C, Igweonu-Nwakile EO, Ali S, Paul S, Yakkali S, Teresa Selvin S, Hamid P.
Systematic Review of Pediatric Brain Tumors in Neurofibromatosis Type 1: Status of Gene Therapy.
Cureus. 2022 Aug 13;14(8):e27963→. doi: 10.7759/cureus.27963→. PMID: 36120213→. Review. ˍ